Type 2 Diabetes Mellitus, Impaired Glucose Tolerance and Associated Comorbidities in Children During 2002–2013 in Children’s Clinical University Hospital, Latvia


The world has seen a rise of type 2 diabetes mellitus in children during the last 20 years. It is proposed that this increase is due to unhealthy eating habits, increasing obesity, especially among teenagers, and better diagnostics. The main risks associated with diabetes are microvascular and macrovascular complications, which can lead to early disability and premature death. The aim of our study was to identify children with type 2 diabetes mellitus or impaired glucose tolerance and investigate associated comorbidities at the time of diagnosis in the Children’s Clinical University Hospital in Latvia. A retrospective analysis was performed of all children with type 2 diabetes mellitus or glucose tolerance impairment from 2002 till 2013, who were treated in Children’s Endocrinology Centre. According to inclusion criteria, 57 patients were selected of whom 24 (42%) had type 2 diabetes mellitus and 33 (58%) had impaired glucose tolerance. Body mass index was analysed according to percentile and all patients were found to have excess weight. In children with type 2 diabetes mellitus, all patients had body mass index over the 99th percentile. Arterial hypertension was found in 66.7% and dyslipidemia in 54.2% type 2 diabetes mellitus patients. From all type 2 diabetes mellitus patients, 71% (n = 17) were girls and they had statistically significantly higher total cholesterol (p = 0.02) and low-density lipoprotein (p = 0.003) levels. Considering, that girls with type 2 diabetes mellitus have high cardiovascular risk in adulthood, it is very important not only to achieve normal glucose levels early, but also to treat comorbidities, to reduce further microvascular and macrovascular complication risk.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • Alizadeh, Z., Khosravi, S., Borna, S. (2013). Obese and overweight children and adolescents: An algorithmic clinical approach. Iranian J. Pediatrics, 23, 621–631.

  • Ball, G. D., Huang, T. T., Gower, B. A., Cruz, M. L., Shaibi, G. Q., Weigensberg, M. J., Goran, M. I. (2006). Longitudinal changes in insulin sensitivity, insulin secretion, and beta-cell function during puberty. J. Pediatr., 148, 16–22.

  • Copeland, K. C., Zeitler, P., Geffner, M., Guandalini, C., Higgins, J., Hirst, K., Kaufman, F. R., Linder, B., Marcovina, S., McGuigan, P., Pyle, L., Tamborlane, W., Willi, S.; TODAYStudy Group. (2011). Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline. J. Clin. Endocrinol. Metab., 96, 159–167.

  • Singh, D., Akingbola, O., Yosypiv, I., El-Dahr, S. (2012). Emergency management of hypertension in children. Int. J. Nephrol., 2012, Article ID 420247, 15 pp.

  • Eppens, M. C., Craig, M. E., Cusumano, J., Hing, S., Chan, A. K., Howard, N. J., Silink, M., Donaghue, K. C. (2006). Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care, 29, 1300–1306.

  • Eyzaguirre, F., Mericq, V. (2009). Insulin resistance markers in children. Horm. Res. Paediatr., 71, 65–74.

  • Godoy-Matos, A., Carraro, L., Vieira, A., Oliveira, J., Guedes, E. P., Mattos, L., Rangel, C., Moreira, R. O., Coutinho, W., Appolinario, J. C. (2005). Treatment of obese adolescents with sibutramine: A randomized, double-blind, controlled study. J. Clin. Endocrinol. Metab., 90, 1460–1465.

  • Halpern, A., Mancini, M.C., Magalhães, M. E. C., Fisberg, M., Radominski, R., Bertolami, M. C., Bertolami, A., de Melo, M. E., Zanella, M. T., Queiroz, M. S., Nery, M. (2010). Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: From diagnosis to treatment. Diabetol. Metab. Syndr., 2, 55.

  • Huang, R. C., Mori, T. A., Burke, V., Newnham, J., Stanley, F. J., Landau, L. I., Kendall, G. E., Oddy, W. H., Beilin, L. J. (2009). Synergy between adiposity, insulin resistance, metabolic risk factors, and inflammation in adolescents. Diabetes Care, 32, 695–701.

  • Kershnar, A. K., Daniels, S. R., Imperatore, G., Palla, S. L., Petitti, D. B., Pettitt, D. J., Marcovina, S., Dolan, L. M., Hamman, R. F., Liese, A. D., Pihoker, C., Rodriguez, B. L. (2006). Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: The SEARCH for Diabetes in Youth Study. J. Pediatr., 149, 314–319.

  • Maahs, D. M., Wadwa, R. P., Bishop, F., Daniels, S., R., Rewers, M., Klingensmith, G. J. (2008). Dyslipidemia in youth with diabetes: To treat or not to treat? J. Pediatr., 153, 458–465.

  • Speiser, P., W., Rudolf, M., C., J., Anhalt, H., Camacho-Hubner, C., Chiarelli, F., Eliakim, A., Freemark, M., Gruters, A., Hershkovitz, E., Iughetti, L., Krude, H., Latzer, Y., Lustig, R. H., Pescovitz, O. H., Pinhas-Hamiel, O., Rogol, A. D., Shalitin, S., Sultan, C., Stein, D., Vardi, P., Werther, G. A., Zadik, Z., Zuckerman-Levin, N., Hochberg, Z. (2005). Consensus statement: Childhood obesity. J. Clin. Endocrinol. Metab., 90, 1871–1887.

  • Pinhas-Hamiel, O., Zeitler, P. (2007). Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet, 369, 1823–1831.

  • Rodbard, H. W., Blonde, L., Braithwaite, S. S., Brett, E. M., Cobin, R. H., Handelsman, Y., Hellman, R., Jellinger, P. S., Jovanovic, L. G., Levy, P., Mechanick, J. I., Zangeneh, F.; AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. (2007). American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocrin. Pract., 13 (Suppl 1), 1–68.

  • Rosenbloom, A. L., Silverstein, J. H., Amemiya, S., Zeitler, P., Klingen-smith, G. J. (2008). Type 2 diabetes mellitus in the child and adolescents. Pediatric Diabetes, 9, 512–526.

  • Wiegand, S., Maikowski, U., Blankenstein, O., Biebermann, H., Tarnow, P., Grüters, A. (2004). Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity: A problem that is no longer restricted to minority groups. Eur. J. Endocrinol., 151, 199–206.

  • Yoon, J. M. (2014). Dyslipidemia in children and adolescents: When and how to diagnose and treat? Pediatric Gastroenterol. Hepatol. Nutr., 17 (2), 85–92.

  • Önal, Z. E., Atasayan, V., Gürbüz, T., Hepkaya, E, Nuhošlu, C. (2014). Association of glycosylated hemoglobin (HbA1c) levels with insulin resistance in obese children. African Health Sci., 14, 533–538.

  • Štāle, M., Skrule, J. (2012). Latvijas iedzīvotāju veselība [Health of Latvian Population]. Slimību profilakses un kontroles centrs, Rīga. 112 lpp.


Journal + Issues